Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription Articles published in Semin Liver Dis Retrieve available abstracts of 84 articles: HTML format

Single Articles

July 2026
1. CARTEE BS, Diniz F, Rai R, Pal PB, et al
   Hepatosystemic T cell licensing in MASLD-associated neuroinflammation.
   Semin Liver Dis. 2026 Jul 6. doi: 10.1055/a-2908-1230.
   PubMed     Abstract available
   
   
   March 2026
2. SU F, Torres-Hernandez A, Hickey R, Shanbhogue K, et al
   Expert Practical Recommendations for Hepatocellular Carcinoma.
   Semin Liver Dis. 2026 Mar 25. doi: 10.1055/a-2832-4720.
   PubMed     Abstract available
   
   
   
3. MAHMUT D, Gouon-Evans V
   Endothelial Cell Therapy for the Acute and Chronic Liver Disease.
   Semin Liver Dis. 2026;46:77-88.
   PubMed     Abstract available
   
   
   
4. ISERTE G, Llarch N, Moon AM, Reig M, et al
   Optimizing Liver Cancer Care Through BCLC Principles.
   Semin Liver Dis. 2026;46:23-30.
   PubMed     Abstract available
   
   
   
5. WEINFURTNER K, Amin R, Skuli N, Gade TP, et al
   Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.
   Semin Liver Dis. 2026;46:51-62.
   PubMed     Abstract available
   
   
   
6. FRANZ A, Shay H, Kirpich I, McClain CJ, et al
   Nutrition and Liver Disease.
   Semin Liver Dis. 2026;46:63-76.
   PubMed     Abstract available
   
   
   December 2025
7. ANTON A, Friedman SL, Cogliati B
   Hepatic fibrosis and liver cancer.
   Semin Liver Dis. 2025 Dec 30. doi: 10.1055/a-2779-4937.
   PubMed     Abstract available
   
   
   
8. BLANEY H, Horhat A, Saleem A, Winder GS, et al
   Integrated Alcohol Use Disorder and Liver Disease Management.
   Semin Liver Dis. 2025;45:517-530.
   PubMed     Abstract available
   
   
   
9. WANG TJ, Singh A
   Endohepatology in the Management of Liver Diseases.
   Semin Liver Dis. 2025;45:439-450.
   PubMed     Abstract available
   
   
   
10. GANGULY S, Sakane S, Hokutan K, Zhang V, et al
    Aging and Aging-Related Senescence in Liver.
    Semin Liver Dis. 2025;45:549-566.
    PubMed     Abstract available
    
    
    
11. SHALABY S, Ramirez-Quesada WE, Ojeda A, Perez-Campuzano V, et al
    Portosinusoidal Vascular Disorder: When to Suspect and How to Manage?
    Semin Liver Dis. 2025;45:487-497.
    PubMed     Abstract available
    
    
    October 2025
12. XU S, Calderaro J
    Combined hepatocellular-cholangiocarcinoma: a clinical and molecular review.
    Semin Liver Dis. 2025 Oct 24. doi: 10.1055/a-2730-9074.
    PubMed     Abstract available
    
    
    September 2025
13. ISRAELSEN M, Trepo E, Krag A, Stender S, et al
    MetALD: Genetic Factors and Clinical Outcomes.
    Semin Liver Dis. 2025;45:269-282.
    PubMed     Abstract available
    
    
    
14. WANG R, Ma F, Yin D, Wang H, et al
    Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2025;45:283-302.
    PubMed     Abstract available
    
    
    
15. MRAVEC B, Szantova M
    Liver Neurobiology: Regulation of Liver Functions by the Nervous System.
    Semin Liver Dis. 2025;45:420-437.
    PubMed     Abstract available
    
    
    
16. CAO P, Jaeschke H, Ni HM, Ding WX, et al
    The Ways to Die: Cell Death in Liver Pathophysiology.
    Semin Liver Dis. 2025;45:397-419.
    PubMed     Abstract available
    
    
    August 2025
17. BALOGUN O, Nejak-Bowen K
    Animal Models of Porphyria with Hepatic Involvement.
    Semin Liver Dis. 2025 Aug 21. doi: 10.1055/a-2677-6806.
    PubMed     Abstract available
    
    
    
18. HASSAN A, Tapper E
    Patient-centered treatment of cirrhosis.
    Semin Liver Dis. 2025 Aug 18. doi: 10.1055/a-2684-6289.
    PubMed     Abstract available
    
    
    June 2025
19. BEIER JI, Luo J, Vanderpuye CM, Brizendine P, et al
    Environmental Pollutants, Occupational Exposures, and Liver Disease.
    Semin Liver Dis. 2025;45:148-166.
    PubMed     Abstract available
    
    
    
20. GRATACOS-GINES J, Alvarado-Tapias E, Marti-Aguado D, Lopez-Pelayo H, et al
    Diagnosis and Management of Early Stages of ALD.
    Semin Liver Dis. 2025;45:195-209.
    PubMed     Abstract available
    
    
    
21. WASHINGTON AM, Kostallari E
    Extracellular Vesicles and Micro-RNAs in Liver Disease.
    Semin Liver Dis. 2025;45:167-179.
    PubMed     Abstract available
    
    
    
22. MARINO Z, Schilsky ML
    Wilson Disease: Novel Diagnostic and Therapeutic Approaches.
    Semin Liver Dis. 2025;45:221-235.
    PubMed     Abstract available
    
    
    
23. BARBERA A, White TM, Arora AK, Henry L, et al
    Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2025;45:210-220.
    PubMed     Abstract available
    
    
    
24. TORRES S, Hardesty J, Barrios M, Garcia-Ruiz C, et al
    Mitochondria and Alcohol-Associated Liver Disease: Pathogenic Role and Target for Therapy.
    Semin Liver Dis. 2025;45:180-194.
    PubMed     Abstract available
    
    
    
25. SINGAL AK
    Preface (Introduction): Metabolic Liver Disease: A New Era in Hepatology.
    Semin Liver Dis. 2025;45:145-147.
    PubMed    
    
    
    May 2025
26. HUANG HYR, Schneider KM, Schneider C
    Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology.
    Semin Liver Dis. 2025 May 21. doi: 10.1055/a-2599-3728.
    PubMed     Abstract available
    
    
    April 2025
27. JIAO H, Wang H, Li J, Yang Z, et al
    The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis.
    Semin Liver Dis. 2025 Apr 16. doi: 10.1055/a-2564-7551.
    PubMed     Abstract available
    
    
    
28. RAMIREZ-QUESADA W, Alvarado-Tapias E, Shalaby S, Hernandez-Gea V, et al
    Recompensation in Cirrhosis: Biomarkers and Strategies.
    Semin Liver Dis. 2025 Apr 3. doi: 10.1055/a-2542-9930.
    PubMed     Abstract available
    
    
    
29. SONG Y, Yang X, Yu C
    Understanding and Treating Hepatorenal Syndrome: Insights from Recent Research.
    Semin Liver Dis. 2025 Apr 1. doi: 10.1055/a-2570-3330.
    PubMed     Abstract available
    
    
    March 2025
30. PANT K, Peixoto E, Gradilone SA
    Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases.
    Semin Liver Dis. 2025 Mar 21. doi: 10.1055/a-2563-9791.
    PubMed     Abstract available
    
    
    
31. SEREROLS-VINAS L, Garcia-Vicien G, Ruiz-Blazquez P, Lee T, et al
    Hepatic stellate cells functional heterogeneity in liver cancer.
    Semin Liver Dis. 2025 Mar 5. doi: 10.1055/a-2551-0724.
    PubMed     Abstract available
    
    
    
32. LIU T, Zhang F, Feng Y, Han P, et al
    Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer.
    Semin Liver Dis. 2025;45:99-113.
    PubMed     Abstract available
    
    
    
33. HILSCHER MB, Johnson JN
    Fontan-Associated Liver Disease.
    Semin Liver Dis. 2025;45:114-128.
    PubMed     Abstract available
    
    
    
34. POHL J, Aretakis D, Tacke F, Engelmann C, et al
    Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2025;45:52-65.
    PubMed     Abstract available
    
    
    
35. ABI-AAD SJ, Lovell M, Khalaf RT, Sokol RJ, et al
    Pathogenesis and Management of Intestinal Failure-Associated Liver Disease.
    Semin Liver Dis. 2025;45:66-80.
    PubMed     Abstract available
    
    
    
36. ZHANG JW, Zhang N, Lyu Y, Zhang XF, et al
    Influence of Sex in the Development of Liver Diseases.
    Semin Liver Dis. 2025;45:15-32.
    PubMed     Abstract available
    
    
    
37. WU Q, Yang D, Liu C, Xu T, et al
    Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury.
    Semin Liver Dis. 2025;45:81-98.
    PubMed     Abstract available
    
    
    
38. ANWAR AA, Jalan-Sakrikar N, Huebert RC
    LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology.
    Semin Liver Dis. 2025;45:1-14.
    PubMed     Abstract available
    
    
    January 2025
39. PREMKUMAR M, Kajal K, Gupta P, Reddy R, et al
    Current Concepts in Fluid Resuscitation and Vasopressor Use in Cirrhosis.
    Semin Liver Dis. 2025 Jan 14. doi: 10.1055/a-2515-2783.
    PubMed     Abstract available
    
    
    November 2024
40. HUDSON D, Valentin Cortez FJ, Hurtado Diaz de Leon I, Malhi G, et al
    Advancements in MELD score and its impact in Hepatology.
    Semin Liver Dis. 2024 Nov 8. doi: 10.1055/a-2464-9543.
    PubMed     Abstract available
    
    
    
41. PRADO LG, Nagy LE
    Role of Complement in Liver Diseases.
    Semin Liver Dis. 2024;44:510-522.
    PubMed     Abstract available
    
    
    
42. POMPILI E, Iannone G, Carrello D, Zaccherini G, et al
    Managing Multiorgan Failure in Acute on Chronic Liver Failure.
    Semin Liver Dis. 2024;44:492-509.
    PubMed     Abstract available
    
    
    
43. SETHI N, Khokhar M, Mathur M, Batra Y, et al
    Therapeutic Potential of Nutraceuticals against Drug-Induced Liver Injury.
    Semin Liver Dis. 2024;44:430-456.
    PubMed     Abstract available
    
    
    
44. MAHER S, Rajapakse J, El-Omar E, Zekry A, et al
    Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:457-473.
    PubMed     Abstract available
    
    
    
45. DE JONG YP
    Mice Engrafted with Human Liver Cells.
    Semin Liver Dis. 2024;44:405-415.
    PubMed     Abstract available
    
    
    October 2024
46. MEENA BL, Sarin SK
    Management of Portal vein Thrombosis in Cirrhosis.
    Semin Liver Dis. 2024 Oct 4. doi: 10.1055/s-0044-1791247.
    PubMed     Abstract available
    
    
    August 2024
47. ARTEEL GE
    Extracellular matrix and hepatic wound healing before fibrosis.
    Semin Liver Dis. 2024 Aug 27. doi: 10.1055/a-2404-7973.
    PubMed     Abstract available
    
    
    
48. BALLESTER MP, Durmazer EN, Qi T, Jalan R, et al
    The value of ammonia as a biomarker in patients with cirrhosis.
    Semin Liver Dis. 2024 Aug 2. doi: 10.1055/a-2378-8942.
    PubMed     Abstract available
    
    
    
49. ZHANG IW, Lurje I, Lurje G, Knosalla C, et al
    Combined Organ Transplantation in Patients with Advanced Liver Disease.
    Semin Liver Dis. 2024;44:369-382.
    PubMed     Abstract available
    
    
    
50. CHOI YJ, Kim Y, Hwang S
    Role of Neutrophils in the Development of Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:300-318.
    PubMed     Abstract available
    
    
    
51. THAKRAL N, Desalegn H, Diaz LA, Cabrera D, et al
    A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD.
    Semin Liver Dis. 2024;44:273-286.
    PubMed     Abstract available
    
    
    
52. CHEN C, Feng D, Wang Y, Yao T, et al
    Necrotic Liver Lesion Resolution: Another Mode of Liver Regeneration.
    Semin Liver Dis. 2024;44:333-342.
    PubMed     Abstract available
    
    
    
53. KOTULKAR M, Paine-Cabrera D, Apte U
    Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer.
    Semin Liver Dis. 2024;44:383-393.
    PubMed     Abstract available
    
    
    
54. QIAN S, Wang X, Chen Y, Zai Q, et al
    Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets.
    Semin Liver Dis. 2024;44:319-332.
    PubMed     Abstract available
    
    
    July 2024
55. TINCOPA MA, Loomba R
    Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis.
    Semin Liver Dis. 2024 Jul 9. doi: 10.1055/s-0044-1788277.
    PubMed     Abstract available
    
    
    May 2024
56. BALOGUN O, Nejak-Bowen K
    Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.
    Semin Liver Dis. 2024 May 17. doi: 10.1055/s-0044-1787076.
    PubMed     Abstract available
    
    
    
57. MA J, Bjornsson ES, Chalasani N
    Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment.
    Semin Liver Dis. 2024 May 13. doi: 10.1055/s-0044-1787062.
    PubMed     Abstract available
    
    
    
58. WERNER W, Kuzminskaya M, Lurje I, Tacke F, et al
    Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
    Semin Liver Dis. 2024;44:159-179.
    PubMed     Abstract available
    
    
    
59. FISCHER AM, Lechea N, Coxson HO
    This Is What Metabolic Dysfunction-Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol.
    Semin Liver Dis. 2024;44:226-238.
    PubMed     Abstract available
    
    
    
60. LI CC, Liu M, Lee HP, Wu W, et al
    Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives.
    Semin Liver Dis. 2024;44:133-146.
    PubMed     Abstract available
    
    
    
61. PHAM N, Benhammou JN
    Statins in Chronic Liver Disease: Review of the Literature and Future Role.
    Semin Liver Dis. 2024;44:191-208.
    PubMed     Abstract available
    
    
    
62. FUJIWARA N, Kimura G, Nakagawa H
    Emerging Roles of Spatial Transcriptomics in Liver Research.
    Semin Liver Dis. 2024;44:115-132.
    PubMed     Abstract available
    
    
    April 2024
63. SAVIANO A, Roehlen N, Baumert TF
    Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Semin Liver Dis. 2024 Apr 22. doi: 10.1055/s-0044-1785646.
    PubMed     Abstract available
    
    
    March 2024
64. KODAMA T, Takehara T
    Molecular genealogy of metabolic-associated hepatocellular carcinoma.
    Semin Liver Dis. 2024 Mar 18. doi: 10.1055/a-2289-2298.
    PubMed     Abstract available
    
    
    February 2024
65. ROMERO-GOMEZ M, Arab JP, Oliveira CP, Hernandez M, et al
    Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
    Semin Liver Dis. 2024;44:69-78.
    PubMed     Abstract available
    
    
    
66. CANIVET CM, Boursier J, Loomba R
    New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
    Semin Liver Dis. 2024;44:35-42.
    PubMed     Abstract available
    
    
    
67. MOUZAKI M, Woo JG, Divanovic S
    Gestational and Developmental Contributors of Pediatric MASLD.
    Semin Liver Dis. 2024;44:43-53.
    PubMed     Abstract available
    
    
    
68. TUTUSAUS A, Morales A, Garcia de Frutos P, Mari M, et al
    GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Semin Liver Dis. 2024;44:99-114.
    PubMed     Abstract available
    
    
    
69. BESSONE F, Hillotte GL, Ahumada N, Jaureguizahar F, et al
    UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
    Semin Liver Dis. 2024;44:1-22.
    PubMed     Abstract available
    
    
    
70. EL-KASSAS M, Awad A, Elbadry M, Arab JP, et al
    Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:54-68.
    PubMed     Abstract available
    
    
    
71. BECH KT, Lindvig KP, Thiele M, Castera L, et al
    Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care Setting.
    Semin Liver Dis. 2024;44:23-34.
    PubMed     Abstract available
    
    
    
72. LIU H, Sethi V, Li X, Xiao Y, et al
    Corrigendum: Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024;44:e1-e3.
    PubMed    
    
    
    January 2024
73. LIU H, Sethi V, Li X, Xiao Y, et al
    Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024 Jan 11. doi: 10.1055/a-2242-7543.
    PubMed     Abstract available
    
    
    November 2023
74. BALOGUN O, Nejak-Bowen K
    The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.
    Semin Liver Dis. 2023 Nov 16. doi: 10.1055/s-0043-1776760.
    PubMed     Abstract available
    
    
    
75. WILSON SR, Duncan AW
    The Ploidy State as a Determinant of Hepatocyte Proliferation.
    Semin Liver Dis. 2023 Nov 15. doi: 10.1055/a-2211-2144.
    PubMed     Abstract available
    
    
    
76. HAN X, Sun Q, Xu M, Zhu G, et al
    Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
    PubMed     Abstract available
    
    
    
77. SAEIDINEJAD M, Elshabrawi A, Sriphoosanaphan S, Andreola F, et al
    Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2023;43:429-445.
    PubMed     Abstract available
    
    
    
78. DUTTA RK, Jun J, Du K, Diehl AM, et al
    Hedgehog Signaling: Implications in Liver Pathophysiology.
    Semin Liver Dis. 2023;43:418-428.
    PubMed     Abstract available
    
    
    August 2023
79. PEKARSKA K, Parker R
    Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?
    Semin Liver Dis. 2023;43:305-310.
    PubMed     Abstract available
    
    
    
80. RANJBARIAN T, Schnabl B
    Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2023;43:311-322.
    PubMed     Abstract available
    
    
    
81. DESHMUKH K, Apte U
    The Role of Endoplasmic Reticulum Stress Response in Liver Regeneration.
    Semin Liver Dis. 2023;43:279-292.
    PubMed     Abstract available
    
    
    
82. MEADOWS V, Yang Z, Basaly V, Guo GL, et al
    FXR Friend-ChIPs in the Enterohepatic System.
    Semin Liver Dis. 2023;43:267-278.
    PubMed     Abstract available
    
    
    
83. COOPER SA, Kostallari E, Shah VH
    Angiocrine Signaling in Sinusoidal Health and Disease.
    Semin Liver Dis. 2023;43:245-257.
    PubMed     Abstract available
    
    
    
84. RUIZ M, Lacaille F, Schrader C, Pons M, et al
    Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Semin Liver Dis. 2023;43:258-266.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum